Is vitamin D deficiency related to a higher risk of hospitalization and mortality in veterans with heart failure?

[1]  W. Grant,et al.  Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths , 2020, Nutrients.

[2]  C. Marcocci,et al.  Vitamin D status and cardiovascular outcome , 2019, Journal of Endocrinological Investigation.

[3]  R. Wachter,et al.  Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction , 2019, ESC heart failure.

[4]  Yi Hao,et al.  Vitamin D levels and vitamin D receptor variants are associated with chronic heart failure in Chinese patients , 2019, Journal of clinical laboratory analysis.

[5]  P. Macdonald,et al.  Impact of Frailty on Mortality and Hospitalization in Chronic Heart Failure: A Systematic Review and Meta‐Analysis , 2018, Journal of the American Heart Association.

[6]  P. Wilson,et al.  The Burden of Frailty Among U.S. Veterans and Its Association With Mortality, 2002-2012. , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[7]  J. Gummert,et al.  Effects of Vitamin D Supplementation on Renin and Aldosterone Concentrations in Patients with Advanced Heart Failure: The EVITA Trial , 2018, International journal of endocrinology.

[8]  G. Rosano,et al.  Frailty in Heart Failure: Implications for Management. , 2018, Cardiac failure review.

[9]  A. Bahaaeldin,et al.  Vitamin D Status in Hospitalized Chronically Ill Patients , 2018, Journal of the American College of Nutrition.

[10]  S. Costanzo,et al.  Serum vitamin D deficiency and risk of hospitalization for heart failure: Prospective results from the Moli-sani study. , 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[11]  D. I. Givens,et al.  Vitamin D intake and risk of CVD and all-cause mortality: evidence from the Caerphilly Prospective Cohort Study , 2017, Public Health Nutrition.

[12]  J. Gummert,et al.  Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily , 2017, European heart journal.

[13]  C. Marcocci,et al.  Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients’ survival , 2017, Endocrine.

[14]  B. Dong,et al.  Association of vitamin D deficiency and frailty: A systematic review and meta-analysis. , 2016, Maturitas.

[15]  M. Sungur,et al.  Vitamin D levels predict hospitalization and mortality in patients with heart failure , 2016, Scandinavian cardiovascular journal : SCJ.

[16]  K. Rockwood,et al.  Frailty and the risk of cognitive impairment , 2015, Alzheimer's Research & Therapy.

[17]  Jianwen Cai,et al.  Modelling recurrent events: a tutorial for analysis in epidemiology. , 2015, International journal of epidemiology.

[18]  G. Onder,et al.  Association of sarcopenia with short- and long-term mortality in older adults admitted to acute care wards: results from the CRIME study. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[19]  M. Whooley,et al.  Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the Heart and Soul Study. , 2014, American journal of epidemiology.

[20]  G. Hankey,et al.  Low vitamin D status is an independent predictor of increased frailty and all-cause mortality in older men: the Health in Men Study. , 2013, The Journal of clinical endocrinology and metabolism.

[21]  Matteo Cesari,et al.  Frailty consensus: a call to action. , 2013, Journal of the American Medical Directors Association.

[22]  A. Keren,et al.  Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome , 2012, European journal of heart failure.

[23]  C. Gordon,et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[24]  D. J. Veldhuisen,et al.  Vitamin D status and outcomes in heart failure patients , 2011, European journal of heart failure.

[25]  H. Brenner,et al.  Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease. , 2010, American heart journal.

[26]  B. Clarridge,et al.  Adverse events during hospitalization: results of a patient survey. , 2008, Joint Commission journal on quality and patient safety.

[27]  K. Alexander,et al.  Frailty and its potential relevance to cardiovascular care. , 2008, Mayo Clinic proceedings.

[28]  G. Tenderich,et al.  Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. , 2006, The American journal of clinical nutrition.

[29]  M. Visser,et al.  Endocrine and inflammatory markers as predictors of frailty , 2005, Clinical endocrinology.

[30]  Yan Chun Li.  Vitamin D regulation of the renin–angiotensin system , 2003, Journal of cellular biochemistry.

[31]  G. Tenderich,et al.  Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? , 2003, Journal of the American College of Cardiology.

[32]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[33]  E. Antman,et al.  ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .

[34]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. , 2002, The Journal of clinical investigation.

[35]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[36]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.